BIOINVENT INTERNATIONAL ABBIOINVENT INTERNATIONAL ABBIOINVENT INTERNATIONAL AB

BIOINVENT INTERNATIONAL AB

No trades
See on Supercharts
Market capitalization
‪1.41 B‬SEK
−5.00SEK
‪−330.30 M‬SEK
‪71.46 M‬SEK
‪43.18 M‬
Beta (1Y)
0.60

About BIOINVENT INTERNATIONAL AB

CEO
Martin Welschof
Headquarters
Lund
Employees (FY)
111
Founded
1997
ISIN
SE0015244520
FIGI
BBG000J8TZY5
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. Its technology platforms include F.I.R.S.T. and n-CoDeR. The company was founded in 1996 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BINV is 23.40 SEK — it has increased by 8.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIOINVENT INTERNATIONAL AB stocks are traded under the ticker BINV.
BIOINVENT INTERNATIONAL AB is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
BINV stock is 13.89% volatile and has beta coefficient of 0.60. Check out the list of the most volatile stocks — is BIOINVENT INTERNATIONAL AB there?
One year price forecast for BIOINVENT INTERNATIONAL AB has a max estimate of 30.00 SEK and a min estimate of 30.00 SEK.
BINV earnings for the last quarter are −1.00 SEK whereas the estimation was −1.17 SEK which accounts for 14.62% surprise. Estimated earnings for the next quarter are −1.27 SEK. See more details about BIOINVENT INTERNATIONAL AB earnings.
BIOINVENT INTERNATIONAL AB revenue for the last quarter amounts to ‪17.92 M‬ SEK despite the estimated figure of ‪8.19 M‬ SEK. In the next quarter revenue is expected to reach ‪9.00 M‬ SEK.
Yes, you can track BIOINVENT INTERNATIONAL AB financials in yearly and quarterly reports right on TradingView.
BINV stock has risen by 25.27% compared to the previous week, the month change is a 40.29% rise, over the last year BIOINVENT INTERNATIONAL AB has showed a 23.03% decrease.
BINV net income for the last quarter is ‪−97.16 M‬ SEK, while the quarter before that showed ‪−71.07 M‬ SEK of net income which accounts for −36.72% change. Track more BIOINVENT INTERNATIONAL AB financial stats to get the full picture.
Today BIOINVENT INTERNATIONAL AB has the market capitalization of ‪1.41 B‬, it has increased by 9.23% over the last week.
No, BINV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BINV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOINVENT INTERNATIONAL AB stock right from TradingView charts — choose your broker and connect to your account.
BINV reached its all-time high on Jun 28, 2001 with the price of 1126.85 SEK, and its all-time low was 14.00 SEK and was reached on Nov 1, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 111.00 employees. See our rating of the largest employees — is BIOINVENT INTERNATIONAL AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOINVENT INTERNATIONAL AB technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOINVENT INTERNATIONAL AB stock shows the sell signal. See more of BIOINVENT INTERNATIONAL AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOINVENT INTERNATIONAL AB future price: according to them, BINV price has a max estimate of 30.00 SEK and a min estimate of 30.00 SEK. Read a more detailed BIOINVENT INTERNATIONAL AB forecast: see what analysts think of BIOINVENT INTERNATIONAL AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOINVENT INTERNATIONAL AB EBITDA is ‪−353.82 M‬ SEK, and current EBITDA margin is −495.13%. See more stats in BIOINVENT INTERNATIONAL AB financial statements.